Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells

Author： Fiskus Warren  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.135, Iss.2, 2012-09, pp. : 433-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells

By                

Oncology Reports, Vol. 30, Iss. 4, 2013-01 ,pp. : 1913-1919

Spandidos Publications

Access to resources Recommend Favorite

Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells

By Uehara Norihisa   Yoshizawa Katsuhiko   Tsubura Airo  

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 105-110

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells

By                  

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1785-1788

Spandidos Publications

Access to resources Recommend Favorite

Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells

By          

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1315-1324

Spandidos Publications

Access to resources Recommend Favorite

Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC

By Preet Ranjan  

Carcinogenesis, Vol. 34, Iss. 2, 2013-02 ,pp. : 277-286

Oxford University Press

Access to resources Recommend Favorite